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THE EFFECT OF Ca2* ON THE INTERACTION OF PROTEIN C WITH 
THROMBIN AND THE ELASTASE FRAGMENT OF THROMBOMODULIN. ANALYSIS 
BY ANALYTICAL ULTRACENTRIFUGATION.
by
Philip H. Olsen 
University of New Hampshire, May, 1991
The effect of Ca2* on the activation of protein C by 
thrombin bound to the elastase fragment of thrombomodulin 
(elTM) is complex. The rate of activation increases from 0 at 
0 mM Ca2* to a maximum at 0.3 mM Ca2* and decreases 25-fold 
upon further addition of Ca2* (Kurosawa et al., 1987). The 
results reported here demonstrate that thrombin, protein C and 
elTM form a complex in the absence of Ca2* that falls apart 
with the addition of Ca2*. This observation, in conjunction 
with the above mentioned kinetic studies, suggests that 
recognition of protein C by thrombin does not require Ca2* but 
that protein C activation requires a Ca2*-induced 
conformational change; probably in protein C. The technique of 
sedimentation equilibrium is used to examine the effect of 
Ca2* on the interaction of this enzyme complex made up of 
three proteins. These proteins studied individually do not 
significantly self-associate. In all experiments, thrombin was 
either inhibited with a tripeptide chloromethyl ketone 
inhibitor (CK), or with diisopropylflourophosphate (DFP).
ix
Thrombin and elTM form a strong 1:1 complex that is relatively 
unperturbed by the addition of Ca2*. Thrombin and protein C 
form two complexes of 1:1 and 1:2 thrombin:protein C 
stoichiometry as suggested by the association model that fits 
the data best. The interactions between thrombin and protein 
C are strongest in 0 mM Ca2*, but become much weaker with the 
addition of Ca2*. Thrombin, protein C and elTM form a single 
1:1:1 complex that behaves similarly to the thrombin/protein 
C mixture upon the addition of Ca2*. Studies with the 42 amino 
acid Gla (7-carboxyglutamic acid) domain peptide and Gla- 
domainless protein C indicate that, at low Ca2* 
concentrations, the interaction of protein C with thrombin and 
elTM may be mediated primarily through this Gla domain. The 
interaction of activated protein C with thrombin alone, and 
thrombin with elTM is also examined. Surprisingly, there is 
little difference in the interaction of activated protein C as 
compared to protein C. This is true regardless of whether the 
thrombin inhibitor is CK which may block some of the substrate 
recognition site, or DFP, which blocks only the catalytic 
site. As suggested by these results, activated protein C is a 




The process of blood coagulation, a series of complex 
proteolytic reactions which are initiated explosively upon 
vascular damage in vivo, leads to an insoluble fibrin/plate­
let clot. A reading of the articles reviewing blood 
coagulation in the last fifteen years clearly demonstrates 
that the process of coagulation is far from simply a linear 
cascade, but is instead a process involving the formation of 
discrete enzyme complexes and multiple feedback pathways 
(Davie and Fujikawa, 1975; Nemerson and Furie, 1980; Jackson 
and Nemerson, 1980; Mann et al., 1988; Furie and Furie, 1988). 
These references are excellent and comprehensive reviews of 
blood coagulation. Nonetheless, let's consider briefly the 
triggering of the cascade, the components involved and the 
regulation of the coagulation process.
Traditionally, the blood coagulation pathway has been 
divided into the intrinsic and extrinsic pathways (see Fig. 1) 
which converge at the activation of factor X (Davie and 
Ratnoff, 1964; MacFarlane, 1964). The intrinsic pathway is 
initiated when plasma comes in contact with a negatively 
charged, nonmembraneous surface, whereas the extrinsic pathway 
is initiated when the endothelial cells lining the blood 
vessels are injured, resulting in the secretion of 
thromboplastin, also known as tissue factor. For several
1
IFigure 1. The Blood Coagulation Cascade. See text for complete 
discussion. The dashed lines show points of 
interconnection between the pathways. PS = protein 
S, a protein cofactor involved in the inactivation 
of factors Va and Villa.
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reasons it is currently thought that the division of blood 
coagulation into two pathways is artificial and not reflective 
of what is relevant in vivo: 1) there are a number of
interconnections between the pathways (dashed lines in Fig. 
1) , and 2) people individually deficient in factor XII, 
prekallikrein (not shown in Fig. l) or HMWK exhibit no 
bleeding disorders(Furie and Furie, 1988). Thus, it appears 
that the coagulation cascade may be a single pathway in vivo.
The components in the coagulation pathway include plasma 
proteins (most of the proteins shown in Fig. 1) , several 
integral membrane proteins, and platelets. Though it is not 
shown in Fig. 1, most of the reactions also require 
phospholipid membranes and calcium ions. For example, optimal 
prothrombin to thrombin conversion requires phospholipid 
membranes, and when they are included in an in vitro reaction 
mixture consisting of factors Xa and Va and calcium, the rate 
of conversion increases nearly 1,000 times over that of the 
mixture without phospholipid membranes (Mann et al., 1986). 
This observation suggests a role for protein/phospholipid 
interactions in addition to the protein/protein interactions 
that are known to exist. Furthermore, these interactions are 
mediated through specific regions of the coagulation proteins.
The blood coagulation proteins have very different 
functional properties, but share a number of structural 
domains (Furie and Furie, 1988). Indeed, all of the enzymes of 
the pathway are serine proteases. A common feature of many of
4
the plasma proteins is an amino-terminal domain cf 
approximately 4b amino acid residues that contains about 10 
carboxyglutamic acid (Gla) residues. These are glutamic acid 
residues which have been modified by a carboxylase, as yet 
unpurified, located in the liver, where most plasma proteins 
involved in coagulation are synthesized (Stenflo and Suttie, 
1977; Furie and Furie, 1990; Vermeer, 1990) . There is evidence 
that the Gla domain can bind negatively charged phospholipid 
membranes, presumably via a calcium ion bridge (Mann et al., 
1982). However, a role in protein/protein interaction via the 
Gla domain should not be excluded (Sakai et al., 1990). 
Another feature commonly found in many of the blood 
coagulation proteins is the epidermal growth factor-like (EGF) 
domain. There is often more than one EGF-like domain in series 
in the sequence (see, for example, Fig. 2) . The EGF-like 
domain was so-named because of its primary sequence similarity 
to a 53 amino acid protein, the epidermal growth factor, first 
identified by Carpenter and Cohen (1979). This domain appears 
to be involved primarily in protein/protein interactions. This 
has been demonstrated, for example, by the binding of 
urokinase to its receptor (Appella et al., 1987), and by a 
study of the functionally important regions of protein S 
(Dahlback et al., 1990).
The enzyme components in the cascade are all synthesized 
as zymogens, so that the process of initiating coagulation is 
essentially one of converting these zymogens to active
5
enzymes. However, once this conversion process has been 
initiated, how is it terminated? In the absence of a rapid and 
effective inhibitory system, it is possible to envision a 
completely clotted plasma pool. The central reaction in blood 
coagulation appears to be the conversion of prothrombin to 
thrombin (see Fig. 1) . Among a number of its procoagulant 
functions, thrombin catalyzes the conversion of soluble 
fibrinogen to insoluble fibrin and amplifies its own 
conversion reaction. It is inhibited by the plasma molecules 
heparin and antithrombin III (Rosenberg and Rosenberg, 1984). 
Recently, it has been shown that thrombin also initiates the 
protein C anticoagulation system (Clouse and Comp, 1986) . This 
system shuts off the thrombin conversion reaction. Thus, as 
soon as the coagulation system is turned on, an 
anticoagulation system is initiated, resulting in the tight 
regulation of the clotting process.
The protein C anticoagulation system
The protein C anticoagulation system consists of three 
proteins: protein C, thrombin, and thrombomodulin (Esmon,
1987; Esmon, 1989). The protein C anticoagulation system was 
postulated to be operative in vivo in 1980 when thrombin was 
found to activate the plasma zymogen protein C at a 
physiologically relevant rate when the proteins were injected 
into a Langendorff heart preparation (Esmon and Owen, 1981) . 
This experiment implied the existence of an endothelial cell
6
surface protein which was then subsequently isolated, 
purified, and named thrombomodulin (TM) (Esmon et al., 1982a).
Protein C is a serine protease zymogen synthesized as a 
single chain in the liver (Fig. 2),and has been isolated from 
bovine and human blood (Stenflo, 1976; Kisiel, 1979). Its 
molecular weight is on the order of 60,000 g/mol. The primary 
sequence of bovine protein C was determined by amino acid 
sequencing (Fernlund and Stenflo, 1982; Stenflo and Fernlund, 
1982), and that of human protein C from the cDNA sequence 
(Foster and Davie, 1984). The mature form of protein C is a 
disulfide linked heterodimer of a light and a heavy chain. The 
light chain contains a Gla domain and 2 EGF-like domains. The 
heavy chain contains the catalytic site. Activation of bovine 
protein C is accomplished by the thrombin catalyzed removal of 
a 14 amino acid activation peptide from the N-terminal of the 
heavy chain (Kisiel et al., 1976). Circular dichroic, 
fluorescence and immunologic studies of protein C have shown 
that large conformational changes take place when the protein 
binds calcium (Johnson et al., 1983; Church et al., 1989). 
Calcium binds to several sites in the Gla domain with an 
affinity of about 200 nM, as well as to a single site in the 
EGF domain that has a Kd of about 50 mM. This latter site 
appears to contain an aspartic acid residue that has been 
posttranslationally modified to 0-HO-aspartic acid (labelled 
Hya in figure 2) (Ohlin et al., 1988). Calcium is required for 
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Figure 2. A model of the bovine protein C molecule. Hya labels 
the 2-hydroxyaspartic acid residue and the arrow 
indicates where thrombin cleaves the heavy chain to 
activate protein C. This figure was adapted from 
that found in the Ph.D. thesis by Ohlin (1989) .
s
physiological rates (Esmon et al., 1983a), even though no 
calcium appears to bind the heavy chain where activation 
occurs. This phenomenon is probably explained by an allosteric 
interaction between the light chain and the heavy chain of 
protein C (Stearns et al., 1988; Orthner et al., 1989).
The action of protein C, once activated, is to inactivate 
factors Villa and Va by proteolytic degradation. These are 
cofactors in the conversion of factor X to Xa and prothrombin 
to thrombin, respectively (Walker et al., 1979; Marlar et al., 
1982) . The inactivation of factors Va and Villa involves 
protein S as a cofactor and is thought to occur on a membrane 
surface. Activated protein C may also be involved in 
fibrinolysis by neutralizing an inhibitor of plasminogen 
activator, thus increasing the level of active plasminogen, a 
fibrinolytic agent (Comp and Esmon, 1981; van Hinsbergh et 
al., 1985).
Thrombin has been introduced in the previous section on 
blood coagulation. This protein is the active form of 
prothrombin which is synthesized in the liver. Thrombin has a 
molecular weight of 37,500 g/mol and can be approximated as a 
sphere with a diameter of 4.5 nm. There are two basic regions 
('lysine patches') thought to be involved in substrate 
binding, and situated on opposite sides of the active site 
cleft (Bode et al., 1989). Thrombin does not appear to bind 
calcium and undergoes no conformational changes in its 
presence. However, when bound to TM, the active site appears
9
to undergo conformational changes (Musci et al., 1988). These 
conformational changes may account for the great improvement 
in thrombin's ability to activate protein C when bound to TM, 
as well as the other concomitant changes in its specificity - 
such as the decreased ability to activate factor V and 
platelets (Esmon et al., 1982b; Esmon et al., 1983b). 
Thrombomodulin also appears to compete with fibrinogen for the 
same binding site on thrombin, preventing the production of 
fibrin molecules (Hofsteenge and Stone, 1987; Jakubowski and 
Owen, 1989) . Thus, there are two effects which result from the 
binding of thrombin to TM: 1) the increase in the activation 
rate of protein C, and 2) the elimination of the procoagulant 
functions of thrombin.
Thrombomodulin is an integral membrane protein with 
molecular weight on the order of 70,000 g/mol (Fig. 3). First 
identified in rabbit heart, it has been isolated from human, 
bovine, mouse, rat, and rabbit (Dittman and Majerus, 1990). It 
is a stable protein that can be subjected to boiling in SDS 
and when repurified, still remains active. However, when 
subjected to reducing agents its function is destroyed (Esmon 
et al. , 1982). Intact TM can be incorporated into phospholipid 
vesicles or used in a 0.02% Lubrol buffer system (Esmon et 
al., 1983;Galvin et al., 1987). However, to further examine 
structure and function relationships, TM was subjected to 
limited proteolysis by a number of proteases (Kurosawa et al., 
1987). TM was cleaved into two major fragments when digested
10
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Figure 3. Schematic model of thrombomodulin. Filled circles 
located within the EGF-like domain represent points 
of putative N-linked glycosylation.
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with either trypsin or elastase. In the case of trypsin, both 
fragments bound phospholipid vesicles, and the larger fragment 
(molecular weight 54,000 g/mol) was active as a cofactor. 
However, only the smaller of the two fragments from the 
elastase digest bound phospholipid vesicles, whereas the 
larger fragment (molecular weight of 50,000 g/mol as 
determined by polyacrylamide gel electrophoresis) was soluble 
in non-detergent containing buffer and functioned as a 
cofactor. This latter fragment has been used extensively in 
protein C activation studies. It is now commonly referred to 
as the elastase fragment of thrombomodulin, or elTM, and is 
shown in Figure 3.
ElTM contains six EGF-like domains which have been shown 
to contain the primary binding site for thrombin, as well as 
the site required for functional activity as a cofactor 
(Suzuki et al., 1989). Specifically, the fifth and sixth EGF 
domains (from the amino terminus) compete with protein C for 
thrombin binding, but this fragment contains no functional 
cofactor activity (Kurosawa et al., 1988). The smallest 
fragment which has functional activity is that which contains 
the fourth, fifth, and sixth EGF domains (Zushi et al., 1989; 
Stearns et al., 1989).
Recently the function of carbohydrate moieties found in 
many of the blood coagulation proteins has received attention. 
Protein C, thrombin and thrombomodulin all contain complex N- 
and O-linked carbohydrate structures. For example, protein C
12
contains nearly 25% carbohydrate by weight depending on 
species (Kisiel, 1979). Furthermore, TM contains two regions 
of N- and O-linked carbohydrate structures (see Fig. 3). The 
O-linked structures appear to be an additional, but secondary 
site of importance for the binding of thrombin (Preissner et 
al., 1990). The N-linked sites do not appear to be necessary 
for thrombin binding (Stearns, et al.,1989).
Kinetics of protein C activation and the objectives of this 
research
The enzyme kinetics of protein C activation is 
particularly complex with respect to its dependence on the 
calcium ion concentration. In this section, discussion is 
devoted to a model of protein C activation by the 
thrombin/thrombomodulin complex that is almost entirely based 
on kinetic evidence. Finally, a summary of research objectives 
is presented.
The current model describing protein C activation by the 
thrombin/TM complex is shown in Figure 4 (taken from Esmon, 
1987). It is based primarily on kinetic studies of the 
activation of protein C by thrombin alone and the thrombin/TM 
or thrombin/elTM complex. While thrombin alone can recognize 
protein C, the conformational change in protein C brought 
about by calcium ions prevents this recognition. However, 
thrombin and thrombomodulin recognize each other regardless of 









Figure 4. This model of protein C activation by the
thrombomodulin/thrombin complex is more fully 
described in the text. Thrombin can bind protein C 
without being bound to thrombomodulin, as long as no 
calcium ions are bound to protein C. The binding of 
thrombin to thrombomodulin alters thrombin's active 
site, allowing thrombin to bind protein C only in 
the presence of calcium ions. Protein C has shared 
binding sites on thrombin, thrombomodulin and the 
plasma membrane. Some of this binding may be 
mediated through protein C's Gla domain (the rounded 
protruding region of protein C in the figure) . BT = 
bovine thrombin. (From Esmon, 1987).
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thrombin/TM interaction results in a conformational change in 
the thrombin active site, enabling it to recognize protein C 
in the presence of calcium ions (Esmon et al., 1983). The Gla 
domain of protein C appears to be necessary for its optimal 
activation. Membrane-incorporated TM/T complex has a ten fold 
smaller (around 0.7 nH) over that of the detergent
solubilized TM/T complex for protein C. The of the
membrane-incorporated TM/T complex for protein C is identical 
to the !<„, determined using cultured endothelial cells (which 
express thrombomodulin on their surface). However, the Km of 
the TM/T complex for Gla-domainless protein C (« 7.0 uM) 
remains unchanged regardless of whether TM is membrane 
incorporated or detergent solubilized (Galvin et al., 1987).
Recently, it has been shown that the T/elTM complex has 
a K„ for protein C similar to that of the membrane 
incorporated TM/T complex. Furthermore, to achieve this 
similar K^ , for protein C by either of the complexes, the 
presence of the Gla domain is required. Thus, it has been 
suggested that the elTM fragment presents a site to protein C 
that is normally exposed when intact TM is incorporated into 
phospholipid vesicles (Kurosawa et al., 1987). It is this site 
which is thought to interact with the Gla domain of protein C. 
This is interesting in that most experimental evidence 
suggests a membrane binding role for the Gla domain. For 
example, the prothrombin Gla domain interacts with membrane 
surfaces (Mann et al., 1982). Therefore, it is thought that
15
the prctein C Gla domain additionally interacts with 
phospholipid membranes.
Finally, a fluorescence study of the molecular 
architecture of the protein C, thrombin and TM complex 
supports the spatial arrangement of these molecules as shown 
in Figure 4 (Lu et al., 1989).
The goals of this research are to further examine the 
physical nature of each of the macromolecules in the protein 
C activation complex, as well as their interactions, 
particularly with regard to their binding energies and 
stoichiometries of association. In place of thrombomodulin, 
the elTM fragment is used since it results in similar kinetic 
parameters for protein C activation as the intact phospholipid 
bound thrombomodulin and is soluble without the use of 
detergents. The macromolecular interactions will be studied as 
a function of the calcium ion concentration and as a function 
of the Gla domain of protein C. The data from these 
experiments will then be used to predict the kinetic behaviour 
of protein C activation and compared with the results from 
kinetics experiments.
The research to be presented in the following pages uses 
several techniques of analytical ultracentrifugation to 
directly study the nature of the protein C activation complex. 
Techniques of this kind have previously been used successfully 
in the study of heterogenous molecular complexes such as the 
structure of Factor Va (Laue et al., 1984) and the interaction
16
of prothrombin with factor Vh (Luckow, 1989; Luckow et al., 
1989) .
The techniques of analytical ultracentrifugation can 
measure association stoichiometries and binding strengths 
between molecules, distinguish between reversible and 
irreversible associating systems and determine general 
molecular shapes. Though this type of data cannot be easily 
obtained by other methods, the techniques of analytical 
ultracentrifugation are not often used because of the 
technical expertise required to run the Spinco Model E 
analytical ultracentrifuge and the difficulty of data 
analysis. A new centrifuge now in design and production should 
eliminate the need for technical expertise (Schachman, 1989). 
The studies done for this dissertation utilize a modified 
Model E analytical ultracentrifuge described in the Materials 




The following proteins were provided by Dr. Charles Esnon 
and were purified using published methods: bovine thrombin
(Owen et al., 1974), rabbit el-TM (Kurosawa et al., 1987), 
bovine protein C (Walker et al., 1979), human protein C 
(Vigano-D'Angelo et al., 1986), Gla-domainless protein C and 
the Gla peptide (Esmon et al., 1983), and activated protein C 
(Vigano-D'Angelo et al., 1986). Calcium chloride hydrate, 
99.99+%, was purchased from Aldrich Chemical Co. Dansyl-L- 
glutamylglycyl-l-arginine chloromethyl ketone and D-phenyl-L- 
prolyl-L-arginine chloromethyl ketone were purchased from 
Calbiochem. The chromogenic substrate, S-2238, was purchased 
from Helena laboratories. All other buffer components were of 
reagent grade.
Pr<?t<?in prepara t i on
Proteins were prepared for analytical ultracentrifugation 
in one of two ways. All proteins were dialyzed in buffer A 
(100 mM NaCl, 50 mM Tris-HCl, pH 7.65, 1 mM Benzamidine)
individually or as mixtures. Before dialysis, thrombin and 
protein C (and its derivatives) were inhibited with D-phenyl- 
L-prolyl-L-arginine chloromethyl ketone or dansyl-L-
glutamylglycyl-L-arginine chloromethyl ketone, respectively 
(Kettner and Shaw, 1981). In some cases, thrombin was 
inhibited with diisopropylfluorophosphate (Esmon et al.,
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1982a) . Proteins were dialyzed in buffer A containing 2 mM 
EDTA, 0.3 mM CaCl., or 5 mM CaCl:. However, and this step is 
where the difference in protein preparation is manifested, for 
many of the short column sedimentation equilibrium 
experiments, Buffer A was treated with Chelex 100 (BioRad) and 
proteins were dialyzed along with Chelex 100 in the dialysate. 
In all cases dialysis was done for a minimum of 60 hours at 
4°C, with three buffer changes. The retentate:dialysate volume 
ratio was a minimum of 1:1000. Protein degradation was 
monitored using SDS-polyacrylamide gel electrophoresis, under 
reducing conditions, by analyzing samples taken before 
dialysis, after dialysis, and after ultracentrifugation 
(Laemmli, 1970). Protein concentrations were estimated using 
the approximate amino acid chain weights and the following 
extinction coefficients (1%, 1 cm) at 280 nm: bovine thrombin, 
21.0 (Owen et al., 1974); bovine el-TM, 6.0 (Kurosawa et al., 
1987); bovine protein C, 13.7 (Kisiel et al., 1976); human 
protein C, 14.5 (Kisiel, 1979); and, Gla-domainless protein C, 
13.7 (Esmon et al., 1983).
Buffer density and partial specific volume
Density and partial specific volume are important 
parameters in the calculation of molecular weight from 
sedimentation data. Buffer A densities, containing 2 mM EDTA, 
0.3 mM CaCl2 or 5 mM CaCl2, were determined at 23.3 °C, using 
the published method (Kratky et al., 1973), with a magnetic 
oscillator density meter (Mettler/Paar model DMA 02 D). The
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values are 1.0040 g/ml for buffer A containing either 2 mM 
EDTA or 0.3 mM CaCl:, and 1.0044 g/ml for buffer A containing 
5 mM CaCl,. EDTA free and calcium free buffers were taken to 
have densities of 1.0040 g/ml.
Protein partial specific volumes were calculated from 
amino acid and carbohydrate composition (Edsall, 1943 ; 
McMeekin and Marshall, 1952). The partial specific volumes of 
amino acids and carbohydrates (Gibbons, 1972) used are good to 
three significant figures.
Sedimentation equilibrium
Both high speed meniscus depletion and short column 
sedimentation equilibrium experiments were used to examine the 
proteins and mixtures of them.
High speed meniscus depletion experiments were done as 
previously described (Yphantis, 1964) with the "externally 
loaded" cell fitted with sapphire windows and containing three 
pairs of solution/solvent channels 3mm in length (Ansevin et 
al., 1970). The solutions contained a single protein or 
equimolar mixtures of two or more of them (the retentate of 
the final dialysis step), and the reference solvent was the 
dialysate from the final step of the protein preparation 
dialysis. All experiments were done at 23.3 °C and 
sedimentation equilibrium data were collected at the indicated 
protein concentrations and rotor speeds.
Short column (0.7 mm) sedimentation equilibrium 
experiments were carried out as previously described
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(Yphantis, 1960) . The advantages of short columns over that of 
3 mm columns are that equilibrium is reached in an hour or two 
as opposed to 2 4 hours, and much smaller quantites of protein 
are required - about five times less. A disadvantage is that 
short columns do not fractionate the protein solution with as 
much resolution.
In most cases, for short column sedimentation equilibrium 
experiments, calcium chloride was added to the retentate and 
dialysate directly, just prior to centrifugation. For 
experiments that used Gla peptide, the peptide was dialyzed 
separately from the other proteins and also added to both the 
solution and reference channnels just prior to centrifugation. 
The volumes and concentrations of CaCl2 or the Gla peptide 
were adjusted appropriately to insure that the only 
thermodynamic difference between the solution and solvent 
columns was the protein, or the proteins, of interest. All 
experiments were done at 23.3 °C and sedimentation data were 
collected at the indicated protein concentrations and rotor 
speeds.
A Beckman Model E analytical ultracentrifuge equipped 
with an electronic speed control, RTIC temperature controller, 
and a HeNe laser light source for Rayleigh interference optics 
was used (Williams, 1978). Data were collected using Kodak 
Technical Pan film and logged into a Vax microcomputer 
(Digital Equipment Corp.) via an automated plate reader for 
earlier experiments. Later experiments utilized the real-time
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data acquisition and analysis system which gathers 
interference fringe data via a solid state TV camera (Laue, 
1981; also, please see Appendix A).
Data were collected at estimated equilibrium times 
(Yphantis, 1964). Verification that equilibrium had been 
reached was done by comparing data with other data taken up to 
two hours after the estimated equilibrium time had been 
reached. Blank corrected data were obtained by subtracting 
blank (using distilled water in the solution/solvent channels) 
interferograms, obtained before and after each experiment, 
from the experimental data (Yphantis, 1964).
Data analysis
Blank correction and data editing were performed using 
the REEDIT program (kindly provided by D. Yphantis). Between 
75 and 400 data points were measured from each interferogram 
with a maximum distance of IOmki between each data point in the 
high gradient region. Data were truncated, to avoid Weiner 
skewing, by excluding fringe gradients above 15 mm/cm2. These 
blank corrected, edited data were analyzed using a nonlinear 
least squares estimation computer program called NONLIN 
(Johnson et al., 1981). This program provides values and the 
65% confidence intervals for the fitted parameters. Data from 
one or more channels, at different loading concentrations, 
radial positions, and rotor speeds can be fit simultaneously 
to a selected model. The simplest model (i.e., the one with 
the fewest fitting parameters) which adequately fits the data
22
is considered to be the "correct" model. This decision is a 
comparative one based on the variance of fit which should 
approximate the experimental noise level, and the degree of 
systematic variations in the residuals of the various models 
examined (Johnson et al., 1981).
Two models were found useful for fitting the data and are 
further described here.
The first model consists of a monomer-dimer (or higher 
oligomer) equilibrium with a hypothetical monomer of molecular 
weight that is the approximate weight average molecular weight 
of the mixture of the associating proteins. Thus,
eg. 1 Y(r) = 6 + efloa + a('2mt,)' +
e ( N t lo a  *■ of - 2B<Y(r> - A |  +  U C )
where Y(r) is the fringe displacement (in fringes) at a radius 
r, S is the baseline offset, a is the monomer activity at the 
arbitrary reference radius r0, a is the reduced molecular 
weight, £=(r2 - r02)/2, B is the coefficient of nonideality, N 
is the stoichiometry of the association, and K is the 
association constant of the complex (Johnson et al., 1981). 
The reduced molecular weight of a component is defined as a = 
M (1 - vo)w2/RT, where M is the molecular weight of the 
component, v is the partial specific volume of the component, 
q is the solvent density, w is the angular velocity of the 
rotor, R is the universal gas constant, and T is the solution
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temperature in degrees kelvin (Yphantis and Waugh, 1956) . This 
model (eg. 1) can be used to describe the sedimentation 
behaviour of individual proteins, but also is appropriate for 
describing heterogenous associations in cases where the 
difference in the reduced molecular weights of the two 
associating species is no more than 2.5 cm2. However, it is 
best if the difference is less than 0.65 cm2 (Luckow et al., 
1989) .
Whereas the model discussed above can be used to 
implicitly describe the fringe displacement data, the 
following model explicitly describes the total fringe 
displacement as the sum of the displacements due to the 
individual components and their reversible complex (-es). This 
model assumes that all components are ideal:
eg? I Y(r) = S + exp{lnaA + cA{> + exp{lnaB + a„£} +
exp{lnaA + lnaB + (aA + a„)£ + lnKAB},
where Y(r) is the fringe displacement (in fringes) at a radius 
r, 6 is the baseline offset, aA and aB are the monomer 
activities of the A and B species at the arbitrary reference 
radius r„, oA and aB are the reduced molecular weights (as 
defined above), £=(r2 - r02)/2, and KAB is the association 
constant of the AB complex (Johnson et al., 1981). This model 
is useful only when there is a difference in the reduced 
molecular weights between A and B of at least 0.65 cm2. It is
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the only model that will give an adequate fit when this 
difference is greater than 2.5 cm; (Luckow et al., 1989). As 
will be seen in the Results section, it was necessary to 
modify this model to describe the experiments describing the 
interaction of thrombin and BPC or BAPC. This is because 
thrombin and protein C apparently form a 1:2 complex in 
addition to a 1:1 complex.
As mentioned earlier, both models return confidence 
intervals. These describe only the precision of the fit to a 
particular model and do not reflect the accuracy of the 
determination. Thus, the error bars to be found in the 
following Results section are only a measure of the precision 
of the determined value. Furthermore, the error bars 
(confidence intervals) are often not symmetric, which is to be 
expected when evaluating nonlinear functions (Johnson et al., 
1981) .
Conversion of units
All fits by NONLIN were done using units of fringe 
displacement. Conversion from the fringe displacement scale to 
other, and more accepted concentration scales was made by 
using the refractive increment of 0.185ml/g at the He-Ne laser 
wavelength of 632.8nm (Perlman and Longsworth, 1948). 
Molecular weights were calculated from the corresponding 
reduced molecular weight returned by NONLIN. The units of the 
association constant lnKfhn|e returned by NONLIN, were converted 
from inverse fringes to inverse molarity units (represented by
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lnKM), by using the best-fit molecular weights for each case 
and the protein refractive increment (Laue et al., 1984) For 
monomer-dimer associating systems:
*m = Kfnnft(M/2) (YT/CT) ,
where M is the monomer molecular weight and YT/CT is the 
specific fringe displacement (3.52 fringes-L/g at 632.8nm). 
For an (A+B)-type association, the corresponding unit 
conversion eguation for the association constant is:
Km = Kfnafe(MAMB/MAB) (Yt/Ct) ,
where MA, MB and MAB are the molecular weights of A, B, and the 
AB complex, respectively. The dissociation constant, Kd was 
calculated by taking the inverse of the association constant. 
The dissociation free energies (a G0') of the complexes were 
calculated using:
a G0' = -RTln (Kd)
where R is the universal gas constant in units of kcal/mole/K 
and T is the temperature in Kelvin. Finally, the nonideality 
coefficient, B, was converted to ml/g by using the best-fit 
value returned by NONLIN and multiplying it by the best-fit 
molecular weight, also returned by NONLIN.
2 6
Assay of protein C activation
This was work was done with Dr. Naomi Esmon in the 
laboratory of Dr. Charles Esmon at the Oklahoma Medical 
Research Foundation, Oklahoma City, OK.
It became clear from the results of sedimentation 
equilibrium experiments that activated protein C might be a 
very good inhibitor of protein C activation. Protein C 
activation by thrombin alone and by thrombin and elTM was done 
under optimal activation conditions as follows. An assay for 
protein C activation has been described previously (Esmon et 
al., 1983b).
Protein C activation by thrombin alone was done in 1.0 mM 
EDTA, 0 . 1  M NaCl, 0 . 0 2  M Tris-HCl, 0 . 1 %  gelatin, pH 7 . 5 ,  37 °c 
for ten minutes. Total reaction volume was 50  pi. The reaction 
was stopped with 10 m 1 of antithrombin III ( 3 5 0  nq/ml final 
concentration). The thrombin concentration was 5 nM and the 
protein C and activated protein C concentrations are indicated 
in the figure legends. Activated protein C for use as an 
inhibitor was inactivated with DEGR and run over a Mono Q ( 0 . 5  
x 5 cm) column (Pharmacia LKB) connected to a protein liquid 
chromatography system. Residual activity of BAPC, was 
quantitated and subtracted from the final results.
Protein C activation by thrombin and elTM was carried out 
similarly to activation by thrombin alone. The reaction time 
was decreased to five minutes and 0.3 mM calcium chloride was 
used instead of EDTA. The elTM concentration was 20 nM and the
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protein c  and BAPC, concentrations are indicated in the figure 
legends. To insure that the elTM was maximally bound by 
thrombin, a mixture of PPACK-inhibited thrombin (15 nM) and 
thrombin (0.08 nM) was used. The PPACK inhibited thrombin was 
prepared by incubating thrombin with PPACK for thirty minutes, 
and then the thrombin was run over a Mono Q column to remove 
excess PPACK. Residual thrombin activity was negligible (>99% 
inhibition). As described above, the reaction was stopped with 
10 m1 of antithrombin III.
The concentration of activated protein C was measured by 
the hydrolysis of H-D-Phe-pipecoyl-Arg-p-nitroanilide (S-2238) 
that was at an initial concentration of 0.2 mM. The reaction 
was monitored at 405 nm with a Molecular Devices 
spectrophotometer at room temperature (21-25 °C) in 0.1 M 
NaCl, 0.02 M Tris-HCl, pH 7.5, 0.1% gelatin. The concentration 
of protein C was determined by using a standard curve that 
related the rate of p-nitroanilide production to the standard 




The partial specific volume is a critical quantity in the 
calculation of molecular weights from the reduced molecular 
weights returned by the nonlinear least squares fitting of 
analytical ultracentrifuge data. A 1% error in the partial 
specific volume translates into a 3% error in the calculated 
molecular weight (Schachman, 1957). Partial specific volumes 
of proteins used in this research are shown in Table 1. The v, 
values in this table are used in the calculation of the 
molecular weights of proteins for this thesis. This is because 
the mean difference between the calculated and measured values 
of the partial specific volume for a number of proteins is 
less using data from Cohn and Edsall as compared to other data 
sets, such as the data set from Zamyatnin (Perkins, 1986) .
Analytical ultracentrifucration of individual proteins
Before examining the combinations of proteins in the 
analytical centrifuge, the sedimentation behaviour of 
individual proteins must be studied. For example, some 
proteins exhibit self-association. This would be an important 
consideration for the proper interpretation of sedimentation 
results of a mixture of several proteins, one of which might 
be self-associating.
Table 2 shows the molecular weights of individual
29
ITable 1: Partial Specific Volumes of Selected Proteins.






BPC 46,800 0.712 0. 699
gdBPC 42,000 0.712 0. 700
BAPC 45,100 0.712 0.700
HPC 47,200 0.711 0. 698
gdHPC 42,400 0.710 0 . 698
HAPC 45,800 0.711 0. 699
elTM 27,400 0. 692 0.681
BT 35,300 0.731 0.717
•Partial specific volumes calculated with data from Cohn &
Edsall (1943) .
"Partial specific volumes calculated with data from Zamyatnin
(1972) .
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Table 2. Properties of the individual components. See text 
for discussion.
‘Cell loading concentration.
bProtein dialyzed against buffer A containing the 
addition listed.
'Simultaneous fit to data acquired at the listed 
rotor speeds.
dMolecular weight determined and the 65% confidence 
interval (in parentheses).
'Product of the second virial coeffeicient and the 
fitted molecular weight and the 65% confidence 
interval (in parentheses).
fSquare root of the variance of fit in units of 
fringe displacement.
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BPC 9 . 42 2 . 0 EDTA 24,28 62,400 0 
(62,200-62,700)
.014
9.42 0.3 Ca2~ 20,24 60,400 0 
(60,100-60,700)
.016
9.42 5.0 Ca2‘ 20,24 61,600 0 
(61,300-61,900)
.016
gdBPC 15.0 2 . 0 EDTA 20,24 54,600 8(6-10) 
28,32(54,200-54,900)
. 019
15. 0 0.3 Ca2* 20,24 55,500 16(13-13) 
28, 32 (55,100-55,800)
. 023
15 . 0 5.0 Ca2* 20,24 55,100 17(15-18) 
28 (54,800-55,300)
. 025
HPC 16.6 2.0 EDTA 20,24 61,400 0 
28,32 (60,900-61,900)
.030
16.6 0.3 Ca2* 20 61,900 0 
(61,100-62,700)
.031
7 . 50 5.0 Ca2+ 20,24 62,400 0 
28,32(62,000-62,800)
.025
gdHPC 10.0 2 . 0 EDTA 20,24 54,100 13(8-18) 
28 (53,500-54,700)
. 024
10.0 0.3 Ca2* 20,24 54,400 13(10-18) 
28 (53,700-55,000)
. 023
10.0 5.0 Ca2 + 20,24 53,600 17(12-22) 
28 (52,800-54,300)
. 027
elTM 18.3 2.0 EDTA 20,24 34,900 0 
28,32(34,700-35,100)
.022
18. 3 0.3 Ca2+ 20,24 34,700 0 
28,32(34,500-34,900)
.018
18.3 5.0 Ca2+ 20,24 34,100 0 
28,32(33,900-34,200)
.022
BTp 42.0 2.0 EDTA 20,24 38,800 0 
28,32(38,600-39,000)
.020
42.0 0.3 Ca2+ 20,24 39,500 0 
28,32(39,200-39,800)
.022




proteins as determined by the standard sedimentation 
equilibrium technique (Yphantis, 1964). Most of the proteins 
were modeled best as ideal monomers, irrespective of whether 
or not the dialysis buffer contained calcium ions. BPC and HPC 
behaved variably depending on the protein preparation. The 
data collected for these two proteins in the presence of 
calcium could sometimes be made to fit a monomer-dimer model 
(dissociation constant on the order of millimolar). However, 
the most consistent model is the ideal monomer model, and this 
was the one chosen to fit the data.
Not clearly evident from Table 2 is that the Gla domain 
of protein C appears to be responsible for the variability 
with regard to self-association, since any tendency toward 
self-association was eliminated when the Gla domainless 
counterparts of BPC and HPC were examined. Prothrombin, 
another protein containing a Gla domain, also exhibits this 
variability (data from T. Laue not shown). However, the Gla- 
domainless counterpart, thrombin, behaves as an ideal monomer.
The short column sedimentation equilibrium technique was 
used to examine the activated form of bovine protein C, BAPC 
(Yphantis, 1960). To activate protein C, a 14 amino acid 
activation peptide is cleaved from the amino terminus of the 
heavy chain. Before sedimentation, BAPC is separated from the 
»1600 g/mol activation peptide. However, the sedimentation 
behaviour of BAPC was similar to that of BPC (Figure 5). The 
molecular weight determined by short column sedimentation
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Figure 5: The z-average molecular weights of BPC and BAPC as 
a function of the Ca:* concentration. See text for 
full discussion. Short column sedimentation 
equilibrium, as described in Materials and Methods, 
was used to determine the sedimentation behaviour of 
BPC (20 mM) and BAPC (20 mM) as a function of the 
calcium chloride concentration. Each point 
represents a simultaneous fit to three speeds: 20, 
24 and 28 thousand rpm.
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Comparison of BPC and BAPC
M z vs. C aC I2 concentration
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equilibrium is a z-average of all the species present. Large 
aggregates are weighted more than lighter ones with this type 
of average. Thus, the observation noted above (that there may 
be some self-association, or aggregation of protein C) is 
supported here. There is an alternative explanation.
Sedimentation velocity studies conducted by the Laue 
laboratory (unpublished) have shown that activation of BPC 
results in the condensing of the protein structure. The 
activation results in a decrease in the partial specific 
volume of the protein, and the concomitant increase in the 
apparent molecular weight, as determined by sedimentation 
equilibrium. The increase in the apparent molecular weight 
occurs despite the lost mass which is due to the removal of 
the activation pep-.ide.
Since BAPC sedimented similarly to BPC, all models used 
to fit experiments involving BAPC utilized the reduced 
molecular weight determined for BPC.
Thus, the sedimentation behaviour of all the proteins was 
essentially invariant with the calcium ion concentration 
and, as a result, an average molecular weight in conditions of 
calcium ions and no calcium ions was calculated and used to 
fit models involving the interactions of two or more proteins. 
Though the Gla domainless protein C molecules exhibited 
detectable nonideality, this fact was neglected for the 
remainder of this study. At the moment, the inclusion of 
nonideality in association models is too complicated.
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Analytical ultracentrifuaation of elTM with BTp
The strongest interaction observed was that between elTM 
and BTp. These results were determined using standard 3 mm 
columns and are shown at the top of Table 3. At the 
concentrations of protein examined, the strength of this 
interaction could not be determined in EDTA. This places an 
upper limit on the dissociation constant of «109 M (Laue et 
al., 1984). The two proteins appeared to behave as a single 
component of 1:1 stoichiometry with an expected molecular 
weight of 73,400 g/mol. The presence of calcium ions weakened 
this interaction, though not significantly until a 
concentration of 5 mM was reached. The best model that was 
found to fit this data was an ideal monomer-dimer model. 
Analytical ultracentrifugation of elTM with BPC. BAPC or gdBPC 
These results form the bulk of the data shown in Table 3. 
As was the case for the elTM/thrombin interaction an ideal 
monomer-dimer model was used to fit the interaction of elTM 
with BPC and BAPC. This interaction was weak and relatively 
calcium ion insensitive. Surprisingly elTM and BAPC interacted 
more strongly than elTM and BPC. That is, the product of the 
activation, activated protein C, interacts more strongly with 
elTM than the substrate, protein C. The weight average 
molecular weight of elTM and gdBPC of 44,850 g/mol is in 
reasonable agreement with the value returned by NONLIN. 
Therefore, it was not possible to detect the presence of an 
interaction between elTM and gdBPC at the protein
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Table 3: The interactions of BTp, BPC, BAPC and gdBPC 
with elTM. See text for discussion.
‘Cell loading concentration of each protein.
bProteins dialyzed against buffer A containing 
the addition listed.
'Simultaneous fit to data acquired at the 
listed rotor speeds.
'’Molecular weight determined and the 65% 
confidence interval (in parentheses).
'Dissociation constant determined between the 
two proteins in the experiment and the 65% 
confidence interval (in parentheses).
fSquare root of the variance of fit in units 
of fringe displacement.
(und = no dissociation constant could be 
detected.
hThis experiment was done using the short 
column centerpiece.
'No addition was made to buffer A in this case, 
but the buffer and glassware was treated as 
described in methods to remove calcium ions. 
Jnone » no association constant could be 
detected.
*This value was held constant during the fit.
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BTp + 21.5 2.0 EDTA 20,24 73,300 und* 0.04 3
elTM (72,500-74,000)
0.3 Ca2 + 20,24 69,900 und 0.032
(68,700-71,000)
20,24 36, 700* 0. 042 0.032
(0.97-0.183)
5.0 Ca2+ 20,24 36,700* 4 . 19 0.040
(3.67-4.74)
BPC + 4.7 2.0 EDTA 15, 20 48,100* 82.0 0.018
elTM (77.0-87.0)
0.3 Ca2t 15,20 48, 100* 71.0 0. 019
(66.0-75.0)
5.0 Ca2* 15,20 48,100* 69.0 0.017
(65.0-74.0)
BAPC* + 7.0 none' 20,24,28 48,100* 35.0 0.008
elTM (31.0-41.0)
0.5 Ca}* 20,24,28 48 , 100* 53.0 0.016
(42.0-67.0)
4.0 Ca2t 20,24,28 48, 100* 52 . 0 0.013
(44.0-61.0)
gdBPC + 5.0 2.0 EDTA 15,20 49,400 none1 0.021
elTM (49,000-49,800)
0.3 Ca2t 15, 20 49,200 none 0 . 020
(48,800-49,600)
5.0 Ca2f 15, 20 51,800 none 0. 046
(51,100-52,800)
concentrations studied. This suggests that the bulk of the 
interaction of elTM and protein C may be mediated directly cr 
indirectly through the Gla domain.
Another way of presenting some of the results in Table 3 
that highlights the calcium dependence of complex formation is 
shown in Figure 6 for the mixture of elTM and BAPC. The dashed 
line in the figure (at M, = 48,100 g/mol) represents the z- 
average molecular weight of elTM and BAPC, and indicates where 
the points should fall if there was no association of the 
proteins. So, using the reasonable assumption from earlier 
results that these proteins do not undergo significant self­
association, this figure demonstrates that there is some 
association between elTM and BAPC. It appears that there may 
be a greater tendency for elTM and BAPC to associate in the 
absence of calcium ions, an observation reflected in Table 3. 
In addition, two separate experiments gave similar results. 
This was a typical example of the reproducibility found during 
the course of this research. Plots of Mj vs. [CaCl2]T0TAL/ like 
Figure 6 , will be used to present all the initial experimental 
results that remain.
Analytical ultracentrifugation of Thrombin with BPC and BAPC
The interaction of thrombin inhibited with D-phenyl-L- 
prolyl-L-arginine chloromethyl ketone (BTp) with BPC and BAPC 
was examined (Figure 7). The interaction between BTp and BPC
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IFigure 6 : The z-average molecular weight of the elTM-BAPC 
complex as a function of the concentration of 
Ca2*. The results shown here are described in the 
text. The dashed line is the weight average 
molecular weight of elTM and BAPC when there is no 
interaction between them. Experiments A and B were 
done with short columns at equimolar protein 
concentrations of 7 and 10 MMolar respectively. Each 
data point represents a simultaneous fit to the data 
from 20, 2 4 and 28 thousand rpm.
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elTM-BAPC Complex  Formation
Mz vs. C aC I2 Concentration
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Figure 7: BPC and BAPC binding to BTP - the z-average
molecular weight of the complexes formed as a 
function of the Ca2* concentration.The results shown 
here are described in the text. These BTp/BAPC and 
BTp/BPC short column experiments were done at 
equimolar protein concentrations of 7.5 and 10 
respectively. Each point represents a simultaneous 
fit of the data to three speeds: 20, 24 and 28 
thousand rpm.
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BPC and BAPC Binding to BTp
M z vs. C aC I2 Concentration
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or BAPC was virtually indistinguishable. Nor were calcium ions 
necessary for the interaction. In fact, the addition of 
calcium chloride immediately weakened the interaction, and in 
4 mM calcium chloride the interaction is nearly undetectable 
as a noninteracting equimolar mixture of BTp and BPC would 
have a molecular weight of 50,300 (the dashed line in Figure 
7)  •
A complex of 1:1 BTp:BPC (BAPC) stoichiometry has a 
molecular weight of 100,600 g/mol, represented by the solid 
line in Figure 7. This is much less than the z-average 
molecular weight determined in 0 mM calcium chloride. It is 
clear that structures with stoichiometries greater than 1:1 
must be present. Therefore, no single Kd is sufficient to 
describe the data.
In order to determine the stoichiometries of the species 
present in the BTp/BPC (BAPC) mixture, a more detailed 
analysis was made at each calcium chloride concentration. 
While there is absolutely no question that a BTpBPC complex is 
present, it is the higher oligomer(s) that is (are) difficult 
to identify. Some of the models tried are compared in Table 4. 
The best model is the last one in the table, which predicts a 
composition of the following four species: 1) BTp; 2) BPC; 3) 
BTpBPC; and, 4) BTpBPC2. This model fit the data consistently 
better than the others based on the root mean square values
45
ITable 4: Comparison of the goodness of fit of 




BTp + BPC <— > BTpBPC 
(monomer - dimer)
BTp BPC < —  > BTpBPC 
(heteroassociation)
2BTp -r 2BPC <--> (BTpBPC), 
(heteroassociation)
2BTp + 2BPC <--> (BTpBPC), 
(monomer - dimer - tetramer)
2BTp + BPC < —  > BTp;BPC . 
(heteroassociation)










Experimental conditions: 10 mM each of BTp and 
BPC in 0 mM calcium chloride buffer, pH 7.6. 
FlUl= 1.062
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returned by NONLIN and the randomness of the residuals. 
Figures 8 and 9 show the dissociation energies, determined 
using this model, of BTpBPC (or BAPC) and BTpBPC; (or BAPC.) 
asa function of the calcium chloride concentration, respec­
tively. Interestingly, the same amount of energy is released 
on addition of the second protein C molecule to thrombin as is 
released when adding the first.
The effect of decreased thrombin inhibitor size on substrate 
vs. product binding
It was surprising to find that BPC and BAPC bound BTp 
with little difference. Since PPACK might be covering or 
blocking several important amino acids in the thrombin 
substrate recognition site necessary for BPC binding, 
diisopropylfluorophosphate (DFP) was used to inhibit thrombin 
(BTd). DFP binds to thrombin's active site serine as 
diisopropylphosphate and probably blocks the arginine pocket.
PPACK, which has the amino acid sequence, Phe-Pro-Arg, is 
a very specific inhibitor of thrombin. In particular, arginine 
sits in the arginine pocket of thrombin and proline and 
phenylalanine both interact with residues in the insertion 
loop segments of thrombin, which define and deepen the active 
site cleft (Bode et al., 1989). This interaction appears to 
prevent substrates from binding to the thrombin active site 
cleft properly.
The binding of BPC and BAPC to BTd, rather than BTp,
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Figure 8 : The free energy of dissociation between the BTp/BPC 
and the BTp/BAPC complexes. This figure is more 
fully described in the text. Using the following 
model, the energy of dissociation of BTp/BPC (or 
BAPC) to BTp and BPC (or BAPC) was determined from 
the data shown in Figure 3 and plotted against the 
calcium chloride concentration:
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IFigure 9: The free energy of dissociation between the BTp/BPC2 
and the BTp/BAPC3 complexes. Using the same model as 
described for figure 8 , the energy of dissociation 
of BTpBPC2 (or BAPC2) to BTpBPC (or BAPC) and BPC (or 
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is shown in Figure 10. As was found with BTp, there does not 
appear to be a great deal of discrimination between BPC and 
BAPC. However, BTd and BPC tend to result reproducibly in 
aslightly higher z-average molecular weight than the BTd and 
BAPC mixture. This may indicate that BTd and BPC interact more 
strongly than BTd and BAPC. The data sets used to produce 
Figure 10 were deconvoluted using the same model that 
describes the BTp/BPC (or BAPC) interaction, because this 
model fit best (Figures 11 and 12). Again, as was found with 
BTp, it appears that the same amount of energy is required to 
add the second protein C molecule as the first. However at 
higher calcium ion concentrations, the second protein C 
molecule seems to be bound less tightly to BTd than when using 
PPACK inhibited thrombin.
Analytical ultracentrifugation of thrombin with elTM and BPC 
and BAPC
Since thrombin was not able to discriminate between BPC 
and BAPC to any large extent, it might be possible that the 
cofactor, elTM, plays an important role in this respect. In 
Figure 13 the interaction of BTp, elTM and BPC (or BAPC) is 
examined, and though there is a difference between the binding 
of BPC and BAPC, it is not large. As was for the case of the 
thrombin and protein C studies, calcium chloride is not 
required for these proteins to interact. In fact, as before, 
the addition of calcium chloride causes their dissociation.
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Figure 10: BPC and BAPC binding to BTd - the z-average
molecular weight of the complexes formed as a 
function of the Ca2* concentration. The results 
shown here are described in the text. These 
BTd/BAPC and BTd/BPC short column experiments were 
done at equimolar protein concentrations of 12.0 
and 12.0 mM, respectively. Each point represents 
the simultaneous fit of data to three speeds: 20, 
24 and 28 thousand rpm.
53
BPC and BAPC Binding to BTd
M z vs. C aC I2 Concentration
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Figure 11: The free energy of dissociation between the BTd/BPC 
and the BTd/BAPC complexes. This figure is more 
fully described in the text. Using the following 
model, the energy of dissociation of BTd/BPC (or 
BAPC) to BTd and BPC (or BAPC) was determined from 
the data shown in Figure 10 and plotted against the 
calcium chloride concentration:
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Figure 12: The free energy of dissociation between the
BTd/BPC: and BTd/BAPC, complexes. Using the same 
model as described for figure 11, the energy 
of dissociation of BTdBPC, (or BAPC,) to BTdBPC (or 
BAPC) and BPC (or BAPC) is plotted as a function of 
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Figure 13: The binding of BPC and BAPC to the elTM/BTp complex 
- the z-average molecular weight of the complexes 
formed as a function of the Ca2* concentration. The 
three proteins were mixed in equimolar 
concentrations (8 mM for the BPC experiment and 7 
mM for the BAPC experiment) and subjected to short 
column sedimentation equilibrium. Each data point 
represents a simultaneous fit of data collected at 
three speeds: 15, 20 and 24 thousand rpm.
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BPC and BAPC Binding to elTM-BTp
M z vs. C aC I2 Concentration
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A similar study was made using DFP inhibited thrombin, with 
much the same result (Figure 14). However, there does seem to 
be a greater difference in the affinity of BPC vs. BAPC for 
elTM/BTd than for elTM/BTp, particularly at the lower calcium 
chloride concentrations. This was previously noted for the 
thrombin and protein C studies (compare Figures 7 and 10).
Using NONLIN, an attempt was made to quantitate the 
stoichiometry of the elTM/BTp/BPC complex and the strength of 
the BPC interaction with the elTM/BTp complex (Table 5). This 
was done for the 0 mM calcium chloride case only, because the 
elTM/BTp complex begins to weaken upon addition of calcium 
ions, and the analysis of a three protein mixture As not 
possible without more data. Thus, the elTM/BTp complex was 
treated as a single protein component and the BPC (or BAPC) as 
the other protein component. The data was well fit in all 
cases with a monomer/dimer model using a monomer molecular 
weight of 67,600 g/mol for experiments involving BPC and BAPC. 
These molecular weights represent half the total molecular 
weight of a 1:1:1 stoichiometry of elTM:BTp:BPC (or BAPC or 
gdBPC). There was no evidence for higher oligomers. A 
dissociation constant of 1 mM corresponds to a dissociation 
free energy between BPC and the elTM/BTp complex of about 8 
kcal/mol.
Analytical ultracentrifuoation of elTM with thrombin and gdBPC
Temporarily setting aside the question of why BPC and
6 1
Figure 14: The binding of BPC and BAPC to the elTM/BTd complex 
- the z-average molecular weight of the complexes 
formed as a function of the Ca2+ concentration.The 
three proteins were mixed in equimolar 
concentrations (8 mM for the BPC experiment and 8 
/iM for the BAPC experiment) and subjected to short 
column sedimentation equilibrium. Each data point 
represents a simultaneous fit of data collected at 
three speeds: 15, 20 and 24 thousand rpm.
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BPC and BAPC Binding to elTM-BTd
M z vs. C aC I2 Concentration
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Table 5: Estimates of the Kd between elTM-BTp(d) BPC, BAPC and gdBPC.

















































“Cell loading concentration of each protein. "No addition was made to buffer A in-this 
case, but the buffer and glassware was treated as described in methods to remove calcium 
ions. 'Simultaneous fit to data acquired at the listed rotor speeds. ’This molecular 
weight was held constant during the fit. 'Dissociation constant determined anil the 65% 
confidence interval (in parentheses). 'Square root of the variance of fit in units of 
fringes.
BAPC appear to recognize thrombin and the thrombin ,'e 17M
complex with very similar affinity, an attempt was made to
examine whether the Gla domain was involved in the recognition
of protein C by the thrombin/elTM complex. Limited digestion
of BPC results in the removal of the Gla domain (the amine
terminal 42 amino acids) from the NH: end of the light chain.
This form of BPC, gdBPC, was centrifuged with BTp and elTM at
a series of calcium chloride concentrations. gdBPC had very
limited interaction with BTp/elTM (Figure 15). The
dissociation constant between gdBPC and elTM/BTp is shown at
the bottom of Table 5. The removal of the Gla domain resulted
in nearly a 100-fold increase in the dissociation constant
over that of BPC with the elTM/BTp complex.
The effect of the Gla peptide on the interaction of thrombin 
and elTM with protein C
Purified Gla peptide from the chymotrypsin digestion of 
BPC was used to assess whether it might bind directly to 
thrombin and elTM. The peptide has a molecular weight, as 
determined from the amino acid sequence, of 4,860 g/mol. Table 
6 shows the results of short column sedimentation equilibrium 
of the Gla peptide in 0 mM calcium chloride. The peptide is in 
a monomer-dimer equilibrium. In the following experiments 
where the peptide was used, it was considered to be fully 
dimerized.
When the Gla peptide was included with equimolar mixtures 
of BTp and BPC or BTp and BAPC, the z-average molecular weight
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Figure 15: The binding of BPC and gdBPC to the elTM/BTp
complex - the z-average molecular weight of the 
complexes formed as a function of the Ca2* 
concentration. The three proteins were mixed in 
equimolar concentrations (8 mM for the BPC 
experiment and 7 mM for the gdBPC experiment) and 
subjected to short column sedimentation 
equilibrium. Each data point represents a 
simultaneous fit of data collected at three speeds: 
15, 2 0 and 24 thousand rpm.
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gdBPC and BPC Binding to elTM-BTp
Mz vs. C a C I2 Concentration
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ITable 6 : Properties of the BPC Gla peptide as determined from 
sedimentation equilibrium in Ca:* depleted buffer. 












35.0 40,48 9, 000 
(8,200-9,900)
und1 0.0085
4,860* 4 . 53 
(2.90-6.82)
• fc-r ..i ____
0.0084
data acquired at the listed rotor speeds. 'Molecular weight 
determined and the 65% confidence interval (in parentheses). 
dMonomer-dimer dissociation constant determined and the 65% 
confidence intervals (in parentheses). 'Square root of the 
variance of fit in units of fringes. fund = undetermined 
*This value was held constant during the fit.
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decreased (Figure 16). This is consistent with the idea that 
BPC and BAPC are being competed off BTp by the peptide. 
Unfortunately, it is not possible to distinguish whether one, 
or both of the protein C molecules are competing with the 
Glpeptide for a binding site. It is unlikely that the Gla 
domain is solely responsible for the interaction of BPC (or 
BAPC) with BTp, since excess peptide failed to completely 
eliminate the BTp/BPC (or BAPC) interaction. If the 
interaction had been eliminated, one would have expected a z- 
average molecular weight of 50,300 g/mol. Furthermore, there 
may be Gla domain specificity since the z-average molecular 
weight of the BTp/BPC mixture decreased from 115,000 g/mol 
with no peptide, to only 105,000 g/mol when 45 m M of Factor X 
Gla peptide was used.
The situation was markedly different when the BPC Gla 
peptide was included with equimolar mixtures of elTM and BTp 
or elTM and BAPC (Figure 17). The z-average molecular weight 
of the elTM/BTp mixture increased by about 10,000 g/mol with 
the addition of 8 mM peptide and did not change with the 
addition of more peptide. This molecular weight gain is what 
would be anticipated if the elTM/thrombin complex is binding 
one Gla peptide dimer. Thus, the result suggests that the 
elTM/BTp complex can bind only one BPC molecule. The 
interaction between elTM and BAPC, as indicated by the z- 
average molecular weight, showed very little change upon 
addition of the Gla peptide. The fact that there was little
6 9
Figure 16: The effect of the Gla peptide on the z-average 
molecular weight of mixtures of BTp/BPC and 
BTp/BAPC. Equimolar mixtures of BTp and BPC (5 /xM) 
and, BTp and BAPC (5 /xM) were titrated with the 
indicated concentrations of Gla peptide in 0 mM 
calcium chloride. Short column sedimentation 
equilibrium was used to determine the z-average 
molecular weight. Each data point represents a 
simultaneous fit to three speeds: 20, 24, and 28 
thousand rpm.
Figure 17: The effect of the Gla peptide on the z-average 
molecular weight of mixtures of elTM/BTp and 
elTM/BAPC.Equimolar mixtures of elTM and BTp (5 /xM) 
and, elTM and BAPC (5 /xM) were titrated with the 
indicated concentrations of Gla peptide in 0 mM 
calcium chloride. Short column sedimentation 
equilibrium was used to determine the z-average 
molecular weight. Each data point represents a 
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competition reflects the weakness of the elTM/BAPC 
interaction. Recalling the result that no interaction could be 
detected between elTM and gdBPC (Table 3), the result here 
suggests that the Gla domain is not directly responsible for 
the interaction between elTM and BPC. Rather, the removal of 
the Gla domain from BPC may induce a conformational change in 
BPC which prevents it from interacting with elTM.
The inhibition of BPC activation bv BAPC
Results discussed earlier indicated that BAPC might be a 
very good inhibitor of BPC activation by both thrombin alone 
and by the elTM/thrombin complex.
This is indeed the case, since it was found that BAPC, 
inhibited with DEGR, inhibits thrombin activation of BPC with 
an apparent Kj of around 0.5 <uM in 0 mM calcium chloride (the 
condition for optimal activation of BPC by thrombin). Figure 
18 shows a typical Dixon plot for this inhibition. This 
apparent Kj is approximately identical to the K,,, of thrombin 
for BPC. It is also nearly the same as the Kd of PPACK or DFP 
inhibited thrombin for BPC (and for BAPC) as determined by 
sedimentation equilibrium in 0 mM calcium chloride (Figures 8 
and 11).
BAPC, inhibited with DEGR, also inhibited the activation 
of BPC by the elTM/thrombin complex in 0.3 mM calcium chloride 
(the optimal condition for BPC activation by the elTM/thombin 
complex). Figure 19 is a representative Dixon plot for this 
inhibition. There was a wide range of apparent Kj values of
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Figure 18: A Dixon plot for the inhibition by BAPC, (BAPC
inhibited with DEGR) of BPC activation by thrombin 
alone in lmM EDTA. The initial concentrations of 
BPC used were 0.4, 0.8 and 1.2 /iMolar. Each point 
represents the average of duplicate 
determinations. Standard deviations were smaller 
than the size of the points.
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BAPC, Inhibition of BPC Activation
by Thrombin
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Figure 19: A Dixon plot for the inhibition of BPC by BAPCj of 
BPC activation by the elTM/thrombin complex in 0.3 
mM calcium chloride. The initial concentrations of 
BPC used were 0.1, 0.2, 0.4 and 0.8 jxMolar. Each 
point represents the average of duplicate 
determinations. Standard deviations were smaller 
than the size of the points.
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BAPC, Inhibition of BPC Activation  
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Ifrom about 3.0-5.0 /xM. Also, the points on the graph in Figure 
19 for 0 m M BAPC, were omitted as they resulted in far too low 
an initial rate. Control experiments later showed that the BPC 
added to the reaction mixtures was sticking to the plastic 
tubes. BPC adhesion to the tubes was not noted for the 
activation of BPC by thrombin alone, because no calcium 
chloride was involved in the reaction. The K, (0.5-1.0 /xM) of 
BAPCj for the elTM/thrombin complex is in good agreement with 
the Kd of BAPCj for the elTM/BTd complex in 0 mM calcium 
chloride as determined by sedimentation equilibrium.
Human versus bovine protein C
The study of differences in the interactions of the 
bovine and the human protein C species with elTM and thrombin 
is incomplete.
Figure 20 shows the effect of Ca2+ on the interaction of 
BTp, elTM, and human protein C. The calcium ion dependence 
appears similar to that seen when using bovine protein C 
(compare with Figure 13). However, it also appears that the 
interaction of HPC with thrombin and elTM is not as strong as 
compared to the interaction of bovine protein C with thrombin 
and elTM.
The following data helps to explain the latter 
observation in that human protein C does not appear to 
interact as strongly as bovine protein C with either thrombin 
or elTM (Table 7). The interaction of thrombin and protein C 
was modeled as a monomer-dimer-tetramer. That is, as a system
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Figure 20: The binding of HPC to the elTM/BTp complex - the z- 
average molecular weight of the complexes formed as 
a function of the Ca2+ concentration. The three 
proteins, human protein C, BTp and elTM were mixed 
in equimolar concentrations (7.1 /iM each) and 
subjected to short column sedimentation 
equilibrium. Each data point represents a 
simultaneous fit of data collected at three speeds: 
15, 20 ahd 24 thousand rpm.
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HPC Binding to elTM-BTp
M z vs. C a C I2 Concentration


















HPC + 7.5 2.0 EDTA 15,20 49,300’ 11.5 0.019
BTp (10.2 - 12.9)
0.3 Ca2+ 15,20 49, 300* 79.4 0. 027
(63.7 - 98.9)




15,20 47 ,900 250 0.019
(47,000-49,000) (190 - 320)
15,20 49,200 250 0.019
(48,300-50,100) (200 - 310)





•Cell loading concentration of each protein. “Proteins dialyzed against buffer A 
containing the addition listed.‘Simultaneous fit to data acquired at the listed rotor 
speeds.‘Molecular weight determined and the 65% confidence interval (in parentheses). 
‘Dissociation constant between the two proteins in the experiment and the 65% confidence 
interval (in parentheses) .'Square root of the variance of fit in units of fringe 
displacement.’This value was held constant during the fit.
consisting of free thrombin and protein C, plus 1:1 and 2:2 
thrombin:protein C complexes. From the more extensive studies 
done with bovine protein C and thrombin, this is probably not 
the correct model. However, as will be noted in the discussion 
section, the selection of the stoichiometry for the second 
complex does not appear to change the value of the 1:1 complex 
dissociation constant. So, for the interaction of human 
protein C with thrombin in Table 7, only the first 
dissociation constant is presented.
The human protein C interaction with elTM was of 1:1 
stoichiometry and relatively Ca2+-independent like the 
interaction of bovine protein C with elTM. However, the 
dissociation constant for the human protein C interaction with 
elTM was nearly four fold weaker.
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DISCUSSION
The activation of protein C by thrombin and elTM is 
complex (Kurosawa et al., 1987). The studies done here suggest 
that the activation of protein C by thrombin alone is 
particularly complicated due to the presence of a 1:2 
thrombin:protein C interaction in addition to the 1:1 
interaction. Ca2+ further complicates the interactions of the 
three proteins in the protein C activation complex. It appears 
that the interaction of primary importance is that between 
protein C and thrombin, and that the Gla domain of protein C 
plays the significant role in the interactions of protein C 
with thrombin and with elTM. The biggest surprise is that 
activated protein C is a potent inhibitor of protein C 
activation by thrombin alone and by thrombin and elTM. In 
addition, there seems to be a species dependence on the 
interaction of human versus bovine protein C with thrombin and 
elTM.
The effect of Ca2+ on the interactions of the three proteins 
in the protein C activation complex
There are four basic combinations that thrombin, elTM and 
protein C can form. They are the thrombin and elTM, the 
thrombin and protein C, the elTM and protein C, and the 
thrombin, elTM and protein C combinations. Each of these 
mixtures was examined as a function of the calcium ion 
concentration.
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IThrombin and elTM - Kinetic studies have revealed that 
the interaction of thrombin and elTM is strong; a result which 
was verified here. This 1:1 elTM:thrombin complex is strong 
enough in the absence of Ca2+ that it was considered as a 
single protein component when modeling the behaviour of the 
thrombin:elTM:protein C mixture. The addition of Ca2+ weakened 
the interaction to detectable levels at 5 mM.
However, though this weakening may not be sufficient to 
explain the decrease in the rate of activation of protein C by 
thrombin and elTM with increasing concentration of Ca2+, this 
result has an impact on the conclusions that can be drawn from 
protein C activation studies done in the presence of 
millimolar amounts of Ca2+. An assumption made in many of the 
kinetic studies examining this calcium ion dependence of 
activation is that there is no change in the affinity of 
thrombin for elTM (for example, Kurosawa et al., 1987), or for 
even smaller fragments of elTM which still retain cofactor 
activity (Hayashi et al., 1990). The Kd of thrombin for elTM 
measured by sedimentation equilibrium was found to be »4 m M in 
5 mM Ca2+. None of the kinetic studies cited above contain 
enough thrombin and elTM (or other catalytic fragment in place 
of elTM) to absorb this change in affinity. In fact, nearly 
all the elTM and thrombin is dissociated at the higher calcium 
concentrations studied.
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Protein C and elTM - The protein CrelTM interaction has 
1:1 stoichiometry, a Kd of around 60 jiM in EDTA or Ca2* 
depleted buffer, and is relatively unaffected by the addition 
of Ca2+. The protein C:elTM interaction is not a likely 
candidate for the decrease in the protein C activation rate 
since this interaction is relatively Ca2+ independent.
Protein C and thrombin - The protein C:thrombin 
interaction is an interaction that is perturbed significantly 
upon the addition of Ca2+. The addition of small amounts of 
Ca2+ (<0.3 mM) has an immediate effect on the weakening of the 
interaction between protein C and thrombin.
Unfortunately, the picture is complicated by the presence 
of an additional complex which has been identified as a 
thrombin:protein C complex with 1:2 stoichiometry. As 
indicated in the Results section, a model incorporating 1:1 
and 1:2 thrombin:protein C complexes fits the data the best. 
The next best model was one which included a 1:1 
thrombin:protein C complex along with a dimer (2:2) of this 
complex. What is most interesting about the comparison of 
these two models is that both of them returned approximately 
similar association energies for the 1:1 thrombin:protein C 
complex. There are several reasons why it is difficult to get 
a firm idea of what the higher order complex may be: 1) there 
is not as much of it relative to the other complex; and, 2) 
its presence is detected primarily in regions of the 
centrifuge cell having the higher concentration gradient, a
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Iless accurate region for analysis (Yphantis, 1964).
Thrombin, elTM and protein C - The interaction of the 
thrombin:elTM:protein C complex has 1:1:1 stoichiometry and 
the effect of Ca2+ on this complex is nearly identical to the 
effect of Ca2 + on the thrombin:protein C complex. There is no 
evidence for complexes of any other stoichiometry. The 
similarity of these results suggests that Ca2+ is somehow 
similarly affecting the affinity of protein C for thrombin and 
the thrombin:elTM complex. This 1:1:1 stoichiometry also 
suggests that elTM may be competing with protein C for a site 
on thrombin.
It was possible to determine a Kd for the affinity of 
protein C for the thrombin:elTM complex in EDTA or Ca2+- 
depleted buffer, because the thrombin:elTM complex can be 
modeled as a single protein under these conditions. The Kd was 
around 1 jxM which is equivalent to an association free energy 
of » -8.0 kcal/mol. The association free energy for thrombin 
and protein C is » -7.5 kcal/mol, and for elTM and protein C 
is » -5.5 kcal/mol. Thus, the binding of protein C to thrombin 
and elTM is apparently noncooperative.
The role of the Gla domain in the interaction of protein C 
with thrombin and elTM
As mentioned in the Introduction, protein C contains two 
known intramolecular regions that bind Ca2+: a /J-hydroxy
aspartic acid residue in the epidermal growth factor-like 
domain, and an amino terminal stretch of residues that
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Icontains from 10 to 12 7-carboxyglutamic acid residues - the 
Gla domain. The affinities for Ca2+ are » 50 fiM and ~ 200 /xM, 
respectively. Kinetic studies have shown that the Gla domain 
is essential for the accelerated rate of protein C activation 
over that of Gla-domainless protein C activation.
Sedimentation equilibrium experiments of Gla-domainless 
protein C with the elTM:thrombin complex are in agreement with 
these results and show that the affinity of Gla-domainless 
protein C for the complex is over 100-fold weaker than the 
affinity of intact protein C for the complex. In addition, the 
removal of the Gla domain from protein C eliminates further 
weakening of the interaction by Ca2+.
When the protein C Gla peptide was included in a mixture 
of protein C and thrombin, the z-average molecular weight of 
the mixture dropped, probably because protein C was being 
competed off thrombin by the Gla peptide. In a mixture of elTM 
and thrombin, the z-average molecular weight increased, 
presumably because the Gla domain was binding to the 
thrombin:elTM complex. Both of these experiments suggest that 
the Gla domain is involved directly in the interaction of 
protein C with thrombin and with the thrombin:elTM complex. 
The Gla domain may also be involved indirectly in these 
interactions.
All of this suggests an extremely important point. It has 
been hypothesized by a number of authors that the interaction 
of protein C with elTM is via a Ca2+ bridge (Kurosawa et al.,
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1987; Hayashi et al., 1990). This is based on the fact that 
there is no detection of protein C activation by the 
thrombin:elTM complex in EDTA, and that this rate increases 
with the addition of Ca2+ up to » 0.3 mM, thereafter
decreasing with the addition of Ca2+, presumably due to the 
dissolution of the Ca2+ bridge. In light of the results from 
sedimentation equilibrium, the model must be modified, because 
there are clearly strong interactions in the absence of Ca2+. 
Thus, since the recognition of the proteins by one another is 
at maximum strength in the absence of Ca2+, it may be only 
that a Ca2+-induced conformational change is required for the 
maximal activation rate.
For the interaction of elTM with thrombin and protein C, 
the role of elTM may include, in addition to the elimination 
of one of two possible sites on thrombin for protein C, a 
means for forcing protein C to adopt a structure on thrombin 
that is optimal for activation. It is not difficult to imagine 
a scheme which might result in the acceleration of protein C 
activation by the thrombin:elTM complex over the rate of 
activation of protein C by thrombin alone.
While it remains unclear what is going on at low Ca2+ 
concentrations, at the higher concentrations it is likely that 
the Gla domain is no longer able to interact with thrombin. 
The direct involvement of the Gla domain with thrombin may be 
via either one or both of the basic residue patches located 
near the active site cleft of thrombin (Bode et al. , 1989),
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and the weakening of the interaction due to Ca2* may be a
result of the elimination of this electrostatic interaction.
A ctivated-, pro te i n C i s  a patent inhibitor of protein c
act iv a tio n
The most surprising discovery during the course of this 
research is that activated protein C is a potent inhibitor of 
protein C activation. This was first suggested by experiments 
which examined the interaction of protein C and activated 
protein C with PPACK inhibited thrombin. No great difference 
in the interactions was noted. This lead to the idea that 
PPACK may be interacting with a number of residues in the 
thrombin active site that are necessary for the discrimination 
between protein C and activated protein C by the thrombin 
active site cleft. In particular, the L-arginine residue of 
PPACK blocks the arginine pocket of thrombin, and the L- 
proline is held in a hydrophobic cage formed by the D- 
phenylalanine of PPACK and a number of amino acid residues of 
thrombin that define the active site cleft (Bode et al.,
1989). Thus, three subsites of the active site cleft of 
thrombin are interacting with PPACK, and this means these 
three subsites cannot interact with protein C or activated 
protein C. Therefore, another much smaller inhibitor was used, 
diisopropyfluorophosphate.
Similar results to those obtained with PPACK-inhibited 
thrombin were observed. Diisopropylphosphate is bound to the 
active site serine of thrombin and probably also blocks the
88
arginine pocket, or subsite 1, of thrombin. Unlike PPACK, this 
molecule probably does not interact significantly with amino 
acids in the other subsites of thrombin that define the active 
site cleft.
When the protein C and activated protein C interactions 
were examined with thrombin and elTM, there was slightly more 
discrimination between protein C and activated protein C. This 
was reflected in the kinetic studies, since activated protein 
C is a better inhibitor of protein C activation by thrombin 
alone than by the thrombin:elTM complex. It is not clear how 
elTM is interacting with thrombin and protein C to bring about 
this discrimination.
It has been shown that the sequence for optimal thrombin 
cleavage on the carboxyl terminal of arginine is P4-P3-Pro- 
Arg-Pl'-P2', where P4 and P3 are hydrophobic residues and P I ' 
and P2 ' are nonacidic residues (Chang, 1985). In protein C all 
these requirements are met except that P3 is an aspartic acid 
residue. Protein C is not a good substrate for thrombin 
without the cofactor thrombomodulin or elTM. The role of elTM 
may be to eliminate the need for a good interaction of the P3 
residue with subsite 3 of thrombin.
The physiological implications of this inhibition of 
protein C activation are unclear at present. These results may 
not be relevant to the activation of protein C by thrombin and 
thrombomodulin in vivo.
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Effect-of human versus bovine protein C on the interactions 
with thrombin and elTM
The study of the interaction of human protein C with 
thrombin and elTM are by no means complete. However, it does 
appear that the interaction of human protein C with both 
thrombin and elTM is not as strong as when bovine protein C is 
used. Both human and bovine protein C contain the same 
functional domains though their sequences are not identical. 
Since the structure of protein C probably plays an important 
role in the interactions with thrombin and elTM, even a small 
difference in sequence identity could give rise to the 
observed interaction differences between human and bovine 
protein C.
Kinetic studies have not been done with human protein C, 
thrombin and elTM. Sedimentation equilibrium results predict 
that human protein C would not be as good a substrate as 
bovine protein C for activation by thrombin and elTM.
Summary
The study of protein interactions is fundamental to the 
understanding of biochemical properties. Recently, a review 
article discussed the nature of protein-protein interactions. 
From an examination of x-ray crystallographic structures of 
protease-inhibitor complexes it was found that there are 
around thirty close-contact residues and about ten hydrogen 
bonds involved in the overall interaction (Janin and Chothia,
1990) . Thus, protein-protein interactions are complicated, and 
the interactions in the protein C activation enzyme complex
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are no exception.
Unfortunately, not all proteins or complexes of proteins 
can be studied by x-ray crystallography. In this study of the 
protein C enzyme complex, the utility of analytical 
ultracentrifugation as a technique for the survey and study of 
protein-protein interactions has been demonstrated. The direct 
involvement of the Gla domain in the interaction with both 
thrombin and with elTM is required for optimal protein C 
activation. The effect of Ca2+ on the rate of protein C 
activation was somewhat clarified. Finally, the possibility of 
potent product inhibition was predicted by analytical 
ultracentrifugation and demonstrated with kinetics.
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APPENDIX A
The work undertaken to study the enzyme complex with the 
analytical ultracentrifuge described in this dissertation 
could not have been completed without some modifications made 
to the Beckman Model E analytical centrifuge.
The fundamental measurement made with the use of the 
centrifuge is that of concentration as a function of radial 
position. There are three optical methods that have been 
designed to do this, and they are the schlieren, absorbance 
and interference optical systems. While each of these systems 
has its own advantages, absorbance and interference optics are 
currently the most utilized.
Absorbance optics permits the use of very low 
concentrations of proteins, and the measurement of absolute 
concentration at any position. It is also possible to use it 
to observe specific proteins in a mixture, provided that the 
extinction coefficient is known and doesn't change with 
association. This is not the typical situation. In addition, 
absorbance measurements are easily automated.
However, measurements made with interference optics are 
more precise than those made using absorbance optics. 
Furthermore, the refractive index of proteins is relatively 
independent of size and association. Used together, the 
absorbance and interference measuring systems would be 
powerful. Unfortunately, at this time, it is not possible to
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Iexamine a mixture of proteins with both methods during a 
single centrifuge run.
Despite the advantages of the interference optical system 
(IOS), it has not been used extensively for the study of 
macromolecular associations because of the difficulty of 
gathering and analyzing data. Typically, photographs of 
interferograms are taken and the necessary measurements are 
made from these photos manually or with an automated measuring 
device. It takes several hours to read a single channel of 
data. The automated reader requires only twenty to thirty 
minutes. However, even this amount of time is prohibitively 
long, since most studies of interest demand a large data set. 
It is also an advantage to be able to examine data as it is 
collected without having to prepare photographs. For example, 
it is then possible to verify quickly during an experiment 
that sedimentation equilibrium has been reached. This is done 
by subtracting data taken at later times from data taken at 
earlier times. Thus, a real time, automated IOS was developed 
based on previous work (for example, Laue, 1981).
A block diagram of the modified real time IOS for the 
Model E (A) is shown in Figure 20. This system can be 
completely operated from a computer terminal. A computer (B) 
receives a rotor timing pulse from (C) , and controls laser (D) 
synchronization with the rotor via a laser pulse controller 
(B). A solid state TV camera (7) sits on a translation stage
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Figure 21: The block diagram of the Model E analytical
ultracentrifuge and the real-time interference 
optical system. See text for full discussion. (A) 
Model E, (B) computer, (C) rotor timing circuit, 
(D) laser, (E) laser pulse controller, (F) TV 
camera, (G) translation stage, and (H) video 
monitor.
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The Modified Model E Analytical Ultracentrifuge
:< i
Figure 21.
that is moved by a micrometer driver (O) . The interferogram is 
displayed on a video monitor (H) from which the computer reads 
frames of data. At the time this research was done, the laser 
pulse controller was not yet installed.
The development of a real-time IOS allowed us to exploit 
the advantages of interference optics, without the 
difficulties mentioned above. Using this system, a single 
channel of data can be read in 10-15 seconds.
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